| Issue Type | Login |
|---|---|
| Country | United States |
| Industry | Login |
| Region | Login |
| Maturity Date | 2097-08-01 |
| Par Value | 1000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 62.42 |
| Coupon | 6.875 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 300 |
| Min. Piece | Login |
| Min. Increment | Login |
This Bristol-Myers Squibb Co. corporate debenture has a 6.88% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 300.00 million USD and matures on August 01, 2097 with a last coupon date of FEB 28, 2020. |
Bristol-Myers Squibb Co., founded in 1887 and headquartered in New York City, is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for patients with serious diseases. The company focuses on a range of therapeutic areas, including oncology, immunology, cardiovascular diseases, and fibrosis, with blockbuster products like Opdivo and Eliquis leading its portfolio.